Evidence map›Paper›PMID 41182902›Full record

ArticleNucleic acids research2025

Nucleosome context regulates chromatin reader preference.

Matthew R Marunde, Irina K Popova, Nathan W Hall, Anup Vaidya, James R Bone, Brandon A Boone, Peter J Brown, Ryan J Ezell, Tessa M Firestone, Harrison A Fuchs and 36 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

Matthew R MarundeEpiCypher Inc., Durham, NC 27709, United States.ORCID 0009-0007-5934-7200
Irina K PopovaEpiCypher Inc., Durham, NC 27709, United States.ORCID 0009-0006-8612-3264
Nathan W HallEpiCypher Inc., Durham, NC 27709, United States.
Anup VaidyaEpiCypher Inc., Durham, NC 27709, United States.ORCID 0009-0007-7817-9986
James R BoneEpiCypher Inc., Durham, NC 27709, United States.
Brandon A BooneEpiCypher Inc., Durham, NC 27709, United States.
Peter J BrownStructural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada.
Ryan J EzellEpiCypher Inc., Durham, NC 27709, United States.
Tessa M FirestoneEpiCypher Inc., Durham, NC 27709, United States.
Harrison A FuchsDepartment of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
Elisa GibsonStructural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada.
Zachary B GillespieEpiCypher Inc., Durham, NC 27709, United States.
Susan L GloorEpiCypher Inc., Durham, NC 27709, United States.ORCID 0000-0001-6911-395X
Allison R HickmanEpiCypher Inc., Durham, NC 27709, United States.
Sarah A HowardEpiCypher Inc., Durham, NC 27709, United States.
Natalia Ledo HusbyEpiCypher Inc., Durham, NC 27709, United States.
Victoria T HsiungEpiCypher Inc., Durham, NC 27709, United States.
Andrea L JohnstoneEpiCypher Inc., Durham, NC 27709, United States.
Laiba F KhanEpiCypher Inc., Durham, NC 27709, United States.
Krzysztof KrajewskiDepartment of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC 27599, United States.
Alexander S LeeDepartments of Chemistry and Molecular Biosciences, the Chemistry of Life Processes Institute, and the Proteomics Center of Excellence, Northwestern University, Evanston, IL 60208, United States.ORCID 0000-0001-6214-1990
Eileen T McAnarneyEpiCypher Inc., Durham, NC 27709, United States.
Keith E MaierEpiCypher Inc., Durham, NC 27709, United States.ORCID 0000-0002-1746-0068
Danielle N MaryanskiEpiCypher Inc., Durham, NC 27709, United States.
Jamie L McCuistonEpiCypher Inc., Durham, NC 27709, United States.
Kelsey E NollEpiCypher Inc., Durham, NC 27709, United States.
Katherine NovitzkyEpiCypher Inc., Durham, NC 27709, United States.
Emily F PattesonEpiCypher Inc., Durham, NC 27709, United States.
Keli L RodriguezEpiCypher Inc., Durham, NC 27709, United States.
Julio C SanchezDepartment of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.
Luis F SchachnerDepartments of Chemistry and Molecular Biosciences, the Chemistry of Life Processes Institute, and the Proteomics Center of Excellence, Northwestern University, Evanston, IL 60208, United States.
Catherine E SmithEpiCypher Inc., Durham, NC 27709, United States.
Lu SunEpiCypher Inc., Durham, NC 27709, United States.
Hailey F TaylorEpiCypher Inc., Durham, NC 27709, United States.
Rachel WatsonEpiCypher Inc., Durham, NC 27709, United States.
Hannah E WillisEpiCypher Inc., Durham, NC 27709, United States.
Catherine A MusselmanDepartment of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States.ORCID 0000-0002-8356-7971
Bryan J VentersEpiCypher Inc., Durham, NC 27709, United States.
Marcus A CheekEpiCypher Inc., Durham, NC 27709, United States.
Matthew J MeinersEpiCypher Inc., Durham, NC 27709, United States.
Zu-Wen SunEpiCypher Inc., Durham, NC 27709, United States.
Neil L KelleherDepartments of Chemistry and Molecular Biosciences, the Chemistry of Life Processes Institute, and the Proteomics Center of Excellence, Northwestern University, Evanston, IL 60208, United States.ORCID 0000-0002-8815-3372
Martis W CowlesEpiCypher Inc., Durham, NC 27709, United States.
Ellen N WeinzapfelEpiCypher Inc., Durham, NC 27709, United States.
Michael-Christopher KeoghEpiCypher Inc., Durham, NC 27709, United States.ORCID 0000-0002-2219-8623
Jonathan M BurgEpiCypher Inc., Durham, NC 27709, United States.

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
TR&D 7: Cell Specific ProteomicsP41GM108569 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2015 to 2024
$13.6M
Molecular mechanisms of histone signaling in a chromatin relevant contextR35GM128705 · NIGMS · UNIVERSITY OF IOWA · PI Catherine Anne Musselman · 2018 to 2026
$3.8M
Chemistry of Life Processes Predoctoral Training ProgramT32GM105538 · NIGMS · NORTHWESTERN UNIVERSITY · PI KELLEHER, NEIL L · 2013 to 2022
$2.7M
Development of efficient quantitative chromatin profiling in kit and high-throughput formatsR44HG010640 · NHGRI · EPICYPHER, INC. · PI KEOGH, MICHAEL-CHRISTOPHER, VENTERS, BRYAN J · 2020 to 2022
$2.4M
Quantitative mapping of combinatorial histone modificationsR44HG010595 · NHGRI · EPICYPHER, INC. · PI BURG, JONATHAN MICHAEL, KEOGH, MICHAEL-CHRISTOPHER · 2021 to 2022
$2.0M
Engineered super-affinity reagents for detection of histone post-translational modificationsR44GM145007 · NIGMS · EPICYPHER, INC. · PI SUN, ZU-WEN · 2022 to 2023
$2.0M
A novel protein engineering tool for rapid manufacturing of designer nucleosomesR44CA214076 · NCI · EPICYPHER, INC. · PI KEOGH, MICHAEL-CHRISTOPHER · 2018 to 2019
$2.0M
Novel enzyme inhibitor screening platform using modified designer nucleosomesR44GM119893 · NIGMS · EPICYPHER, INC. · PI SUN, ZU-WEN · 2019 to 2020
$1.9M
High-throughput methyltransferase assays using recombinant nucleosome substratesR44GM117683 · NIGMS · EPICYPHER, INC. · PI SUN, ZU-WEN · 2018 to 2019
$1.7M
Barcoded nucleosomes for analyzing combinatorial epigenetic regulatorsR44GM116584 · NIGMS · EPICYPHER, INC. · PI SUN, ZU-WEN · 2017 to 2018
$1.6M
Development of highly specific and renewable chromatin labelling reagentsR43GM134834 · NIGMS · EPICYPHER, INC. · PI JOHNSTONE, ANDREA LYNN · 2019 to 2019
$300k
Boehringer IngelheimChemistry of Life Processes Predoctoral Training 5T32GM105538-10Innovative Medicines Initiative 875510Janssen, Merck KGaANCI NIH HHS P30 CA016086NCI NIH HHS R44 CA214076NHGRI NIH HHS R44 HG010595NHGRI NIH HHS R44 HG010640NIGMS NIH HHS P41 GM108569NIGMS NIH HHS R35 GM128705NIGMS NIH HHS R43 GM134834NIGMS NIH HHS R44 GM116584NIGMS NIH HHS R44 GM117683NIGMS NIH HHS R44 GM119893NIGMS NIH HHS R44 GM145007NIGMS NIH HHS T32 GM105538NIH HHS P41GM108569NIH HHS R35GM128705NIH HHS R43GM134834NIH HHS R44CA214076NIH HHS R44GM116584NIH HHS R44GM117683NIH HHS R44GM119893NIH HHS R44GM145007NIH HHS R44HG010595NIH HHS R44HG010640Northwestern UniversityOntario Genomics Institute OGI-196PfizerStructural Genomics Consortium 1097737Takeda
6 · The paper itself

Abstract

Chromatin is more than a simple genome packaging system but rather locally distinguished by histone post-translational modifications (PTMs) that can directly change nucleosome structure and/or be "read" by chromatin-associated proteins to mediate downstream events. An accurate understanding of histone PTM binding preference is vital to explain normal function and pathogenesis and has revealed multiple therapeutic opportunities. Such studies most often use histone peptides, though these cannot represent the full regulatory potential of nucleosome context. Here we apply a range of complementary and easily adoptable biochemical and genomic approaches to interrogate fully defined peptide and nucleosome targets with a diversity of mono- or multivalent chromatin readers. In the resulting data, nucleosome context consistently refined reader binding, and multivalent engagement was more often regulatory than simply additive. This included abrogating binding of the Polycomb group malignant brain tumor (MBT) protein L3MBTL1 to lysine methylated histone tails and confirmation that the CBX7 chromodomain and AT-hook-like motif (CD-ATL) tandem act as a functional unit to confer specificity for H3K27me3. These in vitro nucleosome preferences were confirmed by in vivo reader-CUT&RUN genomic mapping. Such data confirms that more representative chromatin substrates provide greater insight into biological mechanism and human disease.

Indexed as

ChromatinHistonesNucleosomesHumansPolycomb Repressive Complex 1Protein BindingProtein Processing, Post-TranslationalChromatinHistonesNucleosomesPolycomb Repressive Complex 1

Identifiers

PMID41182902
PMCPMC12582028

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.